Home › Narcolepsy › Ohio
Pag-aaral pangklinika para sa Narcolepsy sa Ohio
7 pag-aaral para sa Narcolepsy ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Cincinnati, Ohio, Cincinnati
- Dublin, Ohio, Dublin
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Cincinnati
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Intrepid Research, LLC, Cincinnati
- The Cleveland Clinic Foundation, Cleveland
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07675135A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Intrepid Research, Cincinnati
- Ohio Sleep Medicine and Neuroscience Institute, Dublin
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07625280A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Canton
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
- at 1 pa
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06767683A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
- Takeda Site 13, Cincinnati
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07633301A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Dublin, Dublin
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07096674Mula sa ClinicalTrials.gov, na-kuha noong Okt 2, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.